Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
Brettle
R P
RP
Royal Infirmary NHS Trust, City Hospital, and Department of Medicine, Royal Infirmary, University of Edinburgh, UK.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000191:economics; D000935:Antifungal Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D017828:Rifabutin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D017828:Rifabutin; D017963:Azithromycin; D015725:Fluconazole; D017291:Clarithromycin